Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Replication | 11 | 2015 | 47 | 2.810 |
Why?
|
| Adenovirus E4 Proteins | 12 | 2015 | 12 | 2.610 |
Why?
|
| Adenovirus E1B Proteins | 11 | 2015 | 12 | 2.590 |
Why?
|
| Adenoviridae | 9 | 2018 | 61 | 2.480 |
Why?
|
| Adenoviruses, Human | 13 | 2015 | 17 | 2.150 |
Why?
|
| Adenoviridae Infections | 6 | 2015 | 9 | 1.840 |
Why?
|
| DNA, Viral | 9 | 2015 | 39 | 1.760 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 30 | 1.000 |
Why?
|
| Streptococcus pneumoniae | 2 | 2017 | 40 | 0.660 |
Why?
|
| Hela Cells | 11 | 2016 | 78 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2008 | 7 | 0.560 |
Why?
|
| Ear, Middle | 1 | 2015 | 8 | 0.530 |
Why?
|
| Otitis Media | 1 | 2015 | 21 | 0.520 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 2 | 0.520 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 30 | 0.510 |
Why?
|
| Fetal Blood | 1 | 2015 | 35 | 0.510 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 39 | 0.510 |
Why?
|
| RNA, Viral | 3 | 2013 | 49 | 0.500 |
Why?
|
| Open Reading Frames | 4 | 2009 | 18 | 0.500 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 4 | 0.500 |
Why?
|
| Cell Nucleus | 7 | 2016 | 105 | 0.490 |
Why?
|
| Lymphocytes | 4 | 2017 | 53 | 0.480 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2015 | 7 | 0.460 |
Why?
|
| Cytoplasm | 4 | 2016 | 30 | 0.430 |
Why?
|
| DNA Damage | 3 | 2006 | 88 | 0.400 |
Why?
|
| Cell Line | 10 | 2018 | 449 | 0.370 |
Why?
|
| Histones | 2 | 2009 | 49 | 0.360 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 4 | 0.360 |
Why?
|
| DNA Replication | 1 | 2009 | 23 | 0.340 |
Why?
|
| Humans | 30 | 2019 | 29093 | 0.330 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2004 | 13 | 0.300 |
Why?
|
| Animals | 11 | 2019 | 7297 | 0.260 |
Why?
|
| DNA-Binding Proteins | 5 | 2009 | 142 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.240 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 2016 | 42 | 0.240 |
Why?
|
| S Phase | 1 | 2003 | 11 | 0.240 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.230 |
Why?
|
| Cell Cycle | 1 | 2003 | 69 | 0.230 |
Why?
|
| Tissue Scaffolds | 2 | 2019 | 386 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Lymphocyte Activation | 2 | 2017 | 80 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.220 |
Why?
|
| Virus Latency | 2 | 2013 | 7 | 0.210 |
Why?
|
| Mutation | 5 | 2009 | 466 | 0.200 |
Why?
|
| Phosphorylation | 4 | 2009 | 225 | 0.200 |
Why?
|
| Adenovirus E1A Proteins | 3 | 2006 | 5 | 0.200 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 9 | 0.200 |
Why?
|
| Genetic Variation | 1 | 2002 | 251 | 0.190 |
Why?
|
| alpha-Galactosidase | 1 | 2019 | 3 | 0.180 |
Why?
|
| Bone Substitutes | 1 | 2019 | 8 | 0.180 |
Why?
|
| Hispanic Americans | 1 | 2016 | 904 | 0.180 |
Why?
|
| Up-Regulation | 2 | 2018 | 183 | 0.180 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 121 | 0.170 |
Why?
|
| Mice | 7 | 2018 | 2368 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2009 | 72 | 0.170 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2018 | 14 | 0.170 |
Why?
|
| Nuclear Proteins | 4 | 2006 | 71 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 33 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2018 | 48 | 0.160 |
Why?
|
| Autophagy | 1 | 2018 | 53 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 90 | 0.160 |
Why?
|
| Viral Proteins | 3 | 2016 | 42 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 680 | 0.150 |
Why?
|
| Glioma | 1 | 2018 | 133 | 0.150 |
Why?
|
| Oncolytic Virotherapy | 2 | 2018 | 19 | 0.150 |
Why?
|
| Nucleocapsid | 1 | 2016 | 6 | 0.140 |
Why?
|
| Virus Assembly | 1 | 2016 | 12 | 0.140 |
Why?
|
| Microtubules | 1 | 2016 | 17 | 0.140 |
Why?
|
| Organelles | 1 | 2015 | 3 | 0.140 |
Why?
|
| Cytological Techniques | 1 | 2015 | 19 | 0.130 |
Why?
|
| Chromosome Mapping | 2 | 2008 | 190 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 17 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2015 | 16 | 0.130 |
Why?
|
| DNA Repair | 2 | 2005 | 50 | 0.130 |
Why?
|
| Rabbits | 1 | 2015 | 185 | 0.130 |
Why?
|
| DNA-Activated Protein Kinase | 3 | 2009 | 3 | 0.120 |
Why?
|
| JC Virus | 1 | 2013 | 23 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 20 | 0.110 |
Why?
|
| Polyomavirus Infections | 1 | 2013 | 21 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2015 | 598 | 0.110 |
Why?
|
| Achilles Tendon | 1 | 2012 | 21 | 0.110 |
Why?
|
| Models, Biological | 3 | 2010 | 373 | 0.110 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 113 | 0.110 |
Why?
|
| Transfection | 2 | 2003 | 192 | 0.110 |
Why?
|
| Oncolytic Viruses | 1 | 2012 | 10 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2012 | 19 | 0.100 |
Why?
|
| Protein-Serine-Threonine Kinases | 2 | 2009 | 44 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2013 | 173 | 0.100 |
Why?
|
| Apoptosis | 2 | 2018 | 337 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 980 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 196 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2016 | 54 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2018 | 666 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 247 | 0.100 |
Why?
|
| Adult | 3 | 2016 | 8420 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2013 | 239 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 131 | 0.090 |
Why?
|
| Reoviridae | 1 | 2009 | 2 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 14 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2005 | 172 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2009 | 8 | 0.090 |
Why?
|
| Adenovirus Infections, Human | 1 | 2009 | 2 | 0.090 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2008 | 1 | 0.090 |
Why?
|
| Chemokine CCL1 | 1 | 2008 | 1 | 0.090 |
Why?
|
| Chemokine CCL17 | 1 | 2008 | 1 | 0.090 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2008 | 2 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 248 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 48 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 77 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 51 | 0.080 |
Why?
|
| Gene Components | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 12 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 9 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2008 | 61 | 0.080 |
Why?
|
| Young Adult | 1 | 2015 | 2402 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2013 | 178 | 0.080 |
Why?
|
| Female | 4 | 2018 | 18164 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 91 | 0.080 |
Why?
|
| Male | 4 | 2016 | 17807 | 0.080 |
Why?
|
| Adolescent | 1 | 2015 | 3254 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 33 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2007 | 52 | 0.070 |
Why?
|
| Gene Expression | 2 | 2006 | 332 | 0.070 |
Why?
|
| North Carolina | 2 | 2016 | 1423 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2007 | 171 | 0.070 |
Why?
|
| African Americans | 1 | 2013 | 1373 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2006 | 118 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 46 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 280 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 350 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 13 | 0.070 |
Why?
|
| Genes, Viral | 1 | 2004 | 3 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2004 | 40 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2004 | 22 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 32 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 69 | 0.060 |
Why?
|
| G1 Phase | 1 | 2003 | 8 | 0.060 |
Why?
|
| Hybrid Cells | 1 | 2003 | 7 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 859 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2002 | 21 | 0.050 |
Why?
|
| Arginine | 1 | 2002 | 17 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 45 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 73 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 152 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 201 | 0.040 |
Why?
|
| Aged | 2 | 2016 | 9487 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 143 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 519 | 0.040 |
Why?
|
| Cell Survival | 1 | 2018 | 272 | 0.040 |
Why?
|
| Phenotype | 2 | 2013 | 629 | 0.040 |
Why?
|
| Hemolysis | 1 | 2017 | 12 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 24 | 0.040 |
Why?
|
| Cell Death | 1 | 2017 | 71 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 47 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 50 | 0.040 |
Why?
|
| Middle Aged | 2 | 2016 | 10829 | 0.040 |
Why?
|
| Demecolcine | 1 | 2016 | 2 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 2016 | 3 | 0.040 |
Why?
|
| Nocodazole | 1 | 2016 | 3 | 0.040 |
Why?
|
| Viral Structural Proteins | 1 | 2016 | 7 | 0.040 |
Why?
|
| Virion | 1 | 2016 | 7 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 92 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 71 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2018 | 573 | 0.030 |
Why?
|
| Brefeldin A | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 21 | 0.030 |
Why?
|
| Autoantigens | 1 | 2015 | 16 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 97 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2005 | 16 | 0.030 |
Why?
|
| Base Sequence | 2 | 2005 | 240 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2015 | 256 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 46 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cystatin C | 1 | 2013 | 28 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 52 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2012 | 2 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2012 | 52 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 587 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 293 | 0.030 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 41 | 0.030 |
Why?
|
| Albuminuria | 1 | 2013 | 176 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 287 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 426 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2012 | 14 | 0.030 |
Why?
|
| RNA | 1 | 2012 | 88 | 0.030 |
Why?
|
| DNA | 1 | 2012 | 204 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 276 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 210 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2010 | 12 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 896 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 345 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 836 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 51 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 30 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 249 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 425 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 799 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 711 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 97 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 5 | 0.020 |
Why?
|
| Serotyping | 1 | 2005 | 14 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3531 | 0.020 |
Why?
|
| Phylogeny | 1 | 2005 | 58 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2004 | 4 | 0.020 |
Why?
|
| Threonine | 1 | 2004 | 10 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 23 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2004 | 8 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2004 | 22 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 42 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2004 | 6 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2004 | 15 | 0.020 |
Why?
|
| Integrins | 1 | 2004 | 20 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 72 | 0.020 |
Why?
|
| Protein Binding | 1 | 2004 | 199 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 141 | 0.020 |
Why?
|
| DNA Primers | 1 | 2004 | 87 | 0.020 |
Why?
|
| Edema | 1 | 2004 | 30 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 64 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 160 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 114 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 205 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 249 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 735 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 507 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 485 | 0.010 |
Why?
|